Hyperlipoproteinemia Type II - 18 Studies Found

Withdrawn : Evaluate the Efficacy and Safety of Lomitapide in Pediatric Patients With Homozygous Familial Hypercholesterolemia on Stable Lipid-lowering Therapy
: Homozygous Familial Hypercholesterolemia
: 2016-04-27
: Drug: Lomitapide Other Name: Juxtapid, Lojuxta
Active, not recruiting : A Clinical Trial to Assess the Long Term Safety and Tolerability of MK-0653H in Japanese Participants With Hypercholesterolemia (MK-0653H-833)
:
  • Hypercholesterolemia
  • Familial Hypercholesterolemia

: 2016-04-20
:
  • Drug: Ezetimibe
  • Drug: Rosuvastatin
Completed : Postprandial Response After Intake of Meals With Different Fatty Acid Composition
:
  • Healthy
  • Familial Hypercholesterolemia

: 2016-03-31
:
  • Dietary Supplement: SFA muffin

Recruiting : Efficacy and Safety of Gemcabene in Patients With Homozygous Familial Hypercholesterolemia on Stable, Lipid-Lowering Therapy (COBALT-1)
: Hypercholesteremia
: 2016-03-12
:
  • Drug: Gemcabene 300 mg 1-300 m
Completed : Study to Evaluate the Effects of MBX-8025 in Patients With HoFH
: Homozygous Familial Hypercholesterolemia
: 2015-05-22
:
  • Other: Run-In Period: Placebo

Completed : A Clinical Trial to Assess the Long Term Safety and Tolerability of MK-0653C in Japanese Participants With Hypercholesterolemia (MK-0653C-384)
:
  • Hypercholesterolemia
  • Heterozygous Familial Hypercholesterolemia

: 2015-05-29
:
  • Drug: EZ 10 mg/Atorva 20 mg FDC

Completed : A Study to Evaluate the Safety of Rosuvastatin in Children and Adolescents With Homozygous Familial Hypercholesterolemia
: Homozygous Familial Hypercholesterolemia (HoFH)
: 2015-04-07
: Drug: Rosuvastatin 20mg Active drug 1 or 2 tablets will be taken taken orally, QD, either in the morning
Recruiting : Evaluation of Lipoproteins
:
  • Hyperlipidemia
  • Hyperlipoproteinemia
  • Hypolipoproteinemia : 1999-11-03
<<< Previous